No Data
No Data
Maxim Group Maintains Citius Pharmaceuticals(CTXR.US) With Buy Rating
Promising Outlook for Citius Pharmaceuticals: Buy Rating Affirmed Amid Product Potential and Strategic Developments
Why Nutanix Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket
Express News | Citius Pharmaceuticals Inc : Maxim Group Adjusts Target Price to $8 From $100 to Reflect 1-for-25 Reverse Stock Split
US Stocks Mixed; Best Buy Posts Downbeat Earnings
When Will Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) Breakeven?
萬軍無兵策天鳳 : When it comes to falling, it will never let you down.